Up next

Autoplay

Rogelio Braceras, MD: Jardiance's Results in the EMPA-REG OUTCOME Trial

0 Views • 08/19/25
Share
Side Effects
Side Effects
Subscribers
0

The therapeutic area head of Clinical Development and Medical Affairs, Metabolism, at Boehringer Ingelheim sat down with MD Mag to detail the post-hoc analysis of the renal-outcome trials.

Show more
0 Comments sort Sort By

Up next

Autoplay